Anemia Drug, Eprex, Recalled by Johnson & Johnson

Johnson & Johnson has announced the recall of close to 200,000 syringes of Eprex, a drug used to treat anemia.

The recall has been announced in 17 countries which includes Europe and Canada, No recall has been announced in the U.S.

The reason for the recall is not due to any adverse side effects but due to certain irregularities in the potency of dosages, which the company seeks to rectify.

Source: Medindia